 Sukriti Nag
Concepts (290)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood-Brain Barrier | 15 | 2019 | 44 | 3.590 |
Why?
| | Brain | 24 | 2021 | 1655 | 2.160 |
Why?
| | Brain Injuries | 7 | 2019 | 58 | 2.120 |
Why?
| | TDP-43 Proteinopathies | 5 | 2021 | 102 | 1.840 |
Why?
| | Lewy Bodies | 7 | 2021 | 193 | 1.790 |
Why?
| | Aging | 16 | 2021 | 1614 | 1.760 |
Why?
| | Olfaction Disorders | 2 | 2021 | 54 | 1.560 |
Why?
| | DNA-Binding Proteins | 5 | 2021 | 264 | 1.360 |
Why?
| | Alzheimer Disease | 10 | 2021 | 1829 | 1.320 |
Why?
| | Angiopoietin-1 | 6 | 2016 | 6 | 1.170 |
Why?
| | Vascular Endothelial Growth Factor A | 7 | 2019 | 70 | 1.160 |
Why?
| | Cerebral Cortex | 5 | 2021 | 206 | 1.140 |
Why?
| | Lewy Body Disease | 3 | 2021 | 106 | 1.080 |
Why?
| | African Americans | 2 | 2021 | 818 | 1.010 |
Why?
| | Rats | 15 | 2019 | 966 | 0.960 |
Why?
| | Brain Edema | 5 | 2011 | 30 | 0.920 |
Why?
| | Dementia | 5 | 2019 | 545 | 0.920 |
Why?
| | Substantia Nigra | 3 | 2021 | 157 | 0.920 |
Why?
| | Aged, 80 and over | 27 | 2021 | 5234 | 0.910 |
Why?
| | Male | 42 | 2021 | 17583 | 0.890 |
Why?
| | Frontotemporal Lobar Degeneration | 2 | 2019 | 27 | 0.860 |
Why?
| | Animals | 22 | 2019 | 5312 | 0.860 |
Why?
| | Amygdala | 1 | 2021 | 56 | 0.840 |
Why?
| | Endothelium, Vascular | 8 | 2005 | 72 | 0.830 |
Why?
| | Temporal Lobe | 2 | 2018 | 112 | 0.780 |
Why?
| | Olfactory Bulb | 1 | 2019 | 13 | 0.770 |
Why?
| | Neocortex | 1 | 2019 | 36 | 0.760 |
Why?
| | Angiopoietin-2 | 4 | 2005 | 4 | 0.710 |
Why?
| | Immunohistochemistry | 7 | 2017 | 494 | 0.700 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2018 | 19 | 0.700 |
Why?
| | Longitudinal Studies | 9 | 2021 | 1452 | 0.690 |
Why?
| | Caveolin 1 | 4 | 2016 | 10 | 0.680 |
Why?
| | Humans | 49 | 2021 | 31481 | 0.670 |
Why?
| | Pituitary Neoplasms | 1 | 2017 | 20 | 0.660 |
Why?
| | Proteins | 2 | 2011 | 94 | 0.640 |
Why?
| | Rats, Wistar | 8 | 2019 | 64 | 0.640 |
Why?
| | Cognition | 7 | 2021 | 1206 | 0.620 |
Why?
| | Female | 35 | 2021 | 18253 | 0.610 |
Why?
| | Neuroprotective Agents | 1 | 2016 | 66 | 0.580 |
Why?
| | Cerebral Ventricle Neoplasms | 2 | 2013 | 6 | 0.580 |
Why?
| | Glioma, Subependymal | 2 | 2013 | 5 | 0.580 |
Why?
| | Memory Disorders | 1 | 2017 | 181 | 0.560 |
Why?
| | Tight Junctions | 4 | 2011 | 29 | 0.560 |
Why?
| | Neovascularization, Pathologic | 4 | 2005 | 68 | 0.550 |
Why?
| | Parkinsonian Disorders | 4 | 2020 | 210 | 0.530 |
Why?
| | Spinal Cord | 4 | 2018 | 99 | 0.520 |
Why?
| | Ependymoma | 1 | 2013 | 14 | 0.490 |
Why?
| | Endothelial Cells | 2 | 2011 | 67 | 0.490 |
Why?
| | Blood Vessels | 2 | 2011 | 19 | 0.480 |
Why?
| | Hippocampus | 1 | 2015 | 295 | 0.470 |
Why?
| | Cold Temperature | 4 | 2008 | 39 | 0.460 |
Why?
| | Fibronectins | 5 | 2019 | 31 | 0.460 |
Why?
| | Brain Diseases | 4 | 2021 | 90 | 0.450 |
Why?
| | Autopsy | 5 | 2021 | 340 | 0.450 |
Why?
| | Aged | 19 | 2021 | 10295 | 0.420 |
Why?
| | Cell Adhesion Molecules | 2 | 2008 | 45 | 0.400 |
Why?
| | RNA, Messenger | 4 | 2005 | 371 | 0.390 |
Why?
| | Neurons | 5 | 2013 | 407 | 0.390 |
Why?
| | Astrocytes | 1 | 2011 | 135 | 0.380 |
Why?
| | Membrane Proteins | 2 | 2008 | 230 | 0.370 |
Why?
| | Neuropsychological Tests | 6 | 2020 | 1300 | 0.360 |
Why?
| | Microscopy, Electron | 3 | 2003 | 100 | 0.360 |
Why?
| | Disease Progression | 5 | 2019 | 861 | 0.360 |
Why?
| | Cognition Disorders | 5 | 2018 | 1075 | 0.350 |
Why?
| | Gene Expression Regulation | 2 | 2008 | 351 | 0.350 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2007 | 8 | 0.340 |
Why?
| | Mycosis Fungoides | 1 | 2007 | 7 | 0.340 |
Why?
| | Horseradish Peroxidase | 4 | 2016 | 5 | 0.340 |
Why?
| | Muscular Diseases | 1 | 2007 | 23 | 0.340 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2007 | 38 | 0.340 |
Why?
| | Severity of Illness Index | 5 | 2021 | 1240 | 0.340 |
Why?
| | Occludin | 3 | 2016 | 13 | 0.330 |
Why?
| | Spinal Cord Neoplasms | 2 | 2020 | 37 | 0.320 |
Why?
| | Angiopoietins | 3 | 2011 | 16 | 0.300 |
Why?
| | Endothelial Growth Factors | 2 | 2002 | 8 | 0.300 |
Why?
| | Depression | 3 | 2016 | 516 | 0.290 |
Why?
| | Pituitary Gland, Posterior | 1 | 2005 | 1 | 0.280 |
Why?
| | Pituitary Gland, Anterior | 1 | 2005 | 2 | 0.280 |
Why?
| | Magnetic Resonance Imaging | 4 | 2017 | 1273 | 0.280 |
Why?
| | Parkinson Disease | 4 | 2017 | 1180 | 0.280 |
Why?
| | Apoptosis | 2 | 2007 | 292 | 0.270 |
Why?
| | Locus Coeruleus | 3 | 2013 | 24 | 0.270 |
Why?
| | Cerebral Amyloid Angiopathy | 2 | 2015 | 101 | 0.270 |
Why?
| | Plaque, Amyloid | 2 | 2015 | 146 | 0.260 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2003 | 4 | 0.260 |
Why?
| | Disease Models, Animal | 4 | 2011 | 832 | 0.250 |
Why?
| | Caveolae | 3 | 2011 | 18 | 0.250 |
Why?
| | Neovascularization, Physiologic | 2 | 2019 | 29 | 0.250 |
Why?
| | Histocytochemistry | 1 | 2003 | 34 | 0.240 |
Why?
| | Membrane Glycoproteins | 1 | 2003 | 111 | 0.240 |
Why?
| | Cohort Studies | 6 | 2018 | 2014 | 0.230 |
Why?
| | Telencephalon | 1 | 2002 | 3 | 0.230 |
Why?
| | Arteriolosclerosis | 2 | 2021 | 48 | 0.220 |
Why?
| | Rhabdoid Tumor | 1 | 2020 | 3 | 0.210 |
Why?
| | Logistic Models | 3 | 2017 | 479 | 0.210 |
Why?
| | Central Nervous System Neoplasms | 1 | 2020 | 19 | 0.200 |
Why?
| | Signal Transduction | 2 | 2016 | 588 | 0.200 |
Why?
| | Independent Living | 2 | 2021 | 257 | 0.200 |
Why?
| | Rats, Inbred WF | 3 | 2005 | 6 | 0.200 |
Why?
| | Illinois | 1 | 2020 | 266 | 0.190 |
Why?
| | Neurofibrillary Tangles | 3 | 2017 | 174 | 0.190 |
Why?
| | Coloring Agents | 2 | 2013 | 16 | 0.190 |
Why?
| | Capillary Permeability | 3 | 2003 | 28 | 0.180 |
Why?
| | Motor Neurons | 1 | 2018 | 21 | 0.180 |
Why?
| | Headache | 2 | 2017 | 52 | 0.180 |
Why?
| | Comorbidity | 1 | 2020 | 562 | 0.180 |
Why?
| | Microscopy, Confocal | 2 | 2011 | 128 | 0.170 |
Why?
| | Facial Pain | 1 | 2017 | 7 | 0.170 |
Why?
| | Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 4 | 0.170 |
Why?
| | Amyloid beta-Peptides | 2 | 2017 | 248 | 0.170 |
Why?
| | Movement | 1 | 2018 | 167 | 0.170 |
Why?
| | Vision Disorders | 1 | 2017 | 26 | 0.170 |
Why?
| | Microvessels | 1 | 2017 | 17 | 0.170 |
Why?
| | Brain Infarction | 1 | 2018 | 78 | 0.170 |
Why?
| | Phosphorylation | 2 | 2016 | 199 | 0.160 |
Why?
| | Vascular Endothelial Growth Factors | 2 | 2011 | 10 | 0.160 |
Why?
| | Fragile X Syndrome | 1 | 2020 | 178 | 0.160 |
Why?
| | Endothelium | 2 | 2011 | 15 | 0.160 |
Why?
| | Linear Models | 1 | 2018 | 276 | 0.160 |
Why?
| | Fluorescent Dyes | 2 | 2011 | 71 | 0.160 |
Why?
| | Age Factors | 1 | 2020 | 943 | 0.160 |
Why?
| | Tuberous Sclerosis | 1 | 2017 | 14 | 0.160 |
Why?
| | Brain Stem | 2 | 2016 | 26 | 0.160 |
Why?
| | Mental Status Schedule | 1 | 2017 | 121 | 0.160 |
Why?
| | Middle Aged | 9 | 2019 | 11209 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor B | 2 | 2009 | 2 | 0.160 |
Why?
| | Epidermal Cyst | 1 | 2016 | 6 | 0.150 |
Why?
| | Time Factors | 4 | 2013 | 1902 | 0.150 |
Why?
| | Hypertension | 3 | 2003 | 283 | 0.150 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 467 | 0.150 |
Why?
| | Brain Chemistry | 1 | 2016 | 53 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 68 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 191 | 0.140 |
Why?
| | Central Nervous System Cysts | 1 | 2015 | 6 | 0.140 |
Why?
| | Visceral Afferents | 1 | 2015 | 4 | 0.140 |
Why?
| | Choroid Plexus | 2 | 2007 | 10 | 0.140 |
Why?
| | Sphenoid Sinus | 1 | 2015 | 15 | 0.140 |
Why?
| | Spinal Cord Dorsal Horn | 1 | 2015 | 9 | 0.140 |
Why?
| | Urinary Incontinence | 1 | 2015 | 25 | 0.140 |
Why?
| | Skin Neoplasms | 1 | 2016 | 85 | 0.140 |
Why?
| | Sclerosis | 1 | 2015 | 69 | 0.140 |
Why?
| | Depressive Disorder, Major | 1 | 2016 | 110 | 0.140 |
Why?
| | Multiple System Atrophy | 1 | 2015 | 42 | 0.140 |
Why?
| | Cell Membrane | 2 | 2007 | 132 | 0.140 |
Why?
| | Skull Base Neoplasms | 1 | 2014 | 18 | 0.130 |
Why?
| | Pineal Gland | 1 | 2014 | 3 | 0.130 |
Why?
| | Immunoenzyme Techniques | 2 | 2005 | 54 | 0.130 |
Why?
| | alpha-Tocopherol | 1 | 2014 | 9 | 0.130 |
Why?
| | gamma-Tocopherol | 1 | 2014 | 9 | 0.130 |
Why?
| | Immunocompetence | 1 | 2013 | 7 | 0.130 |
Why?
| | Neuroma, Acoustic | 1 | 2013 | 10 | 0.130 |
Why?
| | Quadriplegia | 1 | 2013 | 8 | 0.130 |
Why?
| | Coccidioidomycosis | 1 | 2013 | 8 | 0.130 |
Why?
| | United States | 1 | 2021 | 2539 | 0.130 |
Why?
| | Apolipoprotein E4 | 1 | 2015 | 218 | 0.130 |
Why?
| | Glioblastoma | 1 | 2013 | 25 | 0.130 |
Why?
| | Mesencephalon | 1 | 2013 | 48 | 0.130 |
Why?
| | Adult | 7 | 2014 | 9779 | 0.130 |
Why?
| | Ki-67 Antigen | 1 | 2013 | 17 | 0.130 |
Why?
| | Radiosurgery | 1 | 2013 | 43 | 0.120 |
Why?
| | alpha-Synuclein | 1 | 2015 | 147 | 0.120 |
Why?
| | Uterine Neoplasms | 1 | 2013 | 13 | 0.120 |
Why?
| | Psychomotor Disorders | 1 | 2013 | 11 | 0.120 |
Why?
| | Leiomyosarcoma | 1 | 2013 | 21 | 0.120 |
Why?
| | Inflammation | 3 | 2007 | 360 | 0.120 |
Why?
| | Vascular Diseases | 1 | 2013 | 59 | 0.120 |
Why?
| | Brain Neoplasms | 1 | 2013 | 187 | 0.110 |
Why?
| | Follow-Up Studies | 4 | 2019 | 2028 | 0.110 |
Why?
| | Blood Proteins | 1 | 2011 | 23 | 0.110 |
Why?
| | Neurosurgical Procedures | 1 | 2013 | 169 | 0.100 |
Why?
| | Antibodies | 1 | 2011 | 72 | 0.100 |
Why?
| | Synapses | 1 | 2011 | 52 | 0.100 |
Why?
| | Cerebrovascular Disorders | 1 | 2011 | 123 | 0.100 |
Why?
| | Aquaporin 1 | 1 | 2009 | 1 | 0.100 |
Why?
| | Aquaporin 4 | 1 | 2009 | 11 | 0.090 |
Why?
| | Matrix Metalloproteinases | 1 | 2009 | 31 | 0.090 |
Why?
| | Prospective Studies | 3 | 2019 | 1934 | 0.090 |
Why?
| | Junctional Adhesion Molecules | 1 | 2008 | 1 | 0.090 |
Why?
| | Receptor, TIE-2 | 2 | 2005 | 2 | 0.090 |
Why?
| | Sural Nerve | 1 | 2007 | 4 | 0.090 |
Why?
| | Neural Conduction | 1 | 2007 | 12 | 0.090 |
Why?
| | Peripheral Nerves | 1 | 2007 | 19 | 0.080 |
Why?
| | Claudin-5 | 1 | 2007 | 4 | 0.080 |
Why?
| | Muscle Weakness | 1 | 2007 | 36 | 0.080 |
Why?
| | Alleles | 2 | 2020 | 221 | 0.080 |
Why?
| | Psychiatric Status Rating Scales | 3 | 2014 | 386 | 0.080 |
Why?
| | Cerebral Arteries | 1 | 2007 | 37 | 0.080 |
Why?
| | Diabetic Ketoacidosis | 1 | 2007 | 1 | 0.080 |
Why?
| | Down-Regulation | 1 | 2007 | 134 | 0.080 |
Why?
| | Skin | 1 | 2007 | 136 | 0.080 |
Why?
| | Biopsy | 1 | 2007 | 283 | 0.080 |
Why?
| | Calcium | 1 | 2011 | 519 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2007 | 242 | 0.080 |
Why?
| | Up-Regulation | 1 | 2007 | 220 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 1 | 2005 | 17 | 0.070 |
Why?
| | Caspase 3 | 1 | 2005 | 29 | 0.070 |
Why?
| | Caspases | 1 | 2005 | 32 | 0.070 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 7 | 0.070 |
Why?
| | Nervous System Diseases | 1 | 2007 | 145 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2007 | 385 | 0.070 |
Why?
| | Prognosis | 1 | 2007 | 1028 | 0.070 |
Why?
| | Memory | 2 | 2018 | 343 | 0.060 |
Why?
| | Gene Expression | 1 | 2005 | 272 | 0.060 |
Why?
| | Encephalitis | 1 | 2003 | 20 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2013 | 3910 | 0.060 |
Why?
| | Microtomy | 1 | 2003 | 1 | 0.060 |
Why?
| | Serum Albumin, Radio-Iodinated | 1 | 2003 | 1 | 0.060 |
Why?
| | Lanthanum | 1 | 2003 | 2 | 0.060 |
Why?
| | Monosaccharides | 1 | 2003 | 2 | 0.060 |
Why?
| | Tissue Embedding | 1 | 2003 | 6 | 0.060 |
Why?
| | Myocardium | 1 | 2004 | 183 | 0.060 |
Why?
| | Pia Mater | 1 | 2003 | 7 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2003 | 11 | 0.060 |
Why?
| | Peroxidases | 1 | 2003 | 7 | 0.060 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2003 | 8 | 0.060 |
Why?
| | CpG Islands | 1 | 2003 | 53 | 0.060 |
Why?
| | Staining and Labeling | 1 | 2003 | 27 | 0.060 |
Why?
| | Capillaries | 1 | 2003 | 15 | 0.060 |
Why?
| | Antigens | 1 | 2003 | 29 | 0.060 |
Why?
| | Basement Membrane | 1 | 2003 | 16 | 0.060 |
Why?
| | Cell Count | 2 | 2013 | 115 | 0.060 |
Why?
| | Pericytes | 1 | 2003 | 14 | 0.060 |
Why?
| | Antigen Presentation | 1 | 2003 | 24 | 0.060 |
Why?
| | Vasoconstriction | 1 | 2003 | 24 | 0.060 |
Why?
| | Calcium-Transporting ATPases | 1 | 2003 | 26 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2004 | 187 | 0.060 |
Why?
| | Chemokines | 1 | 2003 | 31 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2003 | 36 | 0.060 |
Why?
| | Bromodeoxyuridine | 1 | 2002 | 8 | 0.060 |
Why?
| | Mitotic Index | 1 | 2002 | 8 | 0.060 |
Why?
| | Cats | 1 | 2003 | 79 | 0.060 |
Why?
| | Electrophysiology | 1 | 2003 | 140 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2002 | 63 | 0.060 |
Why?
| | Mitochondria | 1 | 2003 | 91 | 0.060 |
Why?
| | Membrane Potentials | 1 | 2003 | 206 | 0.060 |
Why?
| | Lymphokines | 1 | 2002 | 13 | 0.060 |
Why?
| | Macrophages | 1 | 2003 | 129 | 0.060 |
Why?
| | Lumbar Vertebrae | 2 | 2018 | 469 | 0.050 |
Why?
| | Cranial Fossa, Posterior | 2 | 2014 | 7 | 0.050 |
Why?
| | Mice | 2 | 2003 | 1894 | 0.050 |
Why?
| | Calcium Signaling | 1 | 2003 | 188 | 0.050 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2020 | 43 | 0.050 |
Why?
| | Models, Biological | 1 | 2003 | 428 | 0.050 |
Why?
| | Frontotemporal Dementia | 1 | 2019 | 10 | 0.050 |
Why?
| | Fragile X Mental Retardation Protein | 1 | 2020 | 107 | 0.050 |
Why?
| | Decompression, Surgical | 1 | 2020 | 146 | 0.050 |
Why?
| | Neuroimaging | 1 | 2019 | 126 | 0.040 |
Why?
| | Child, Preschool | 1 | 2020 | 786 | 0.040 |
Why?
| | Microglia | 1 | 2018 | 131 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2018 | 128 | 0.040 |
Why?
| | Young Adult | 2 | 2015 | 2277 | 0.040 |
Why?
| | Retrospective Studies | 2 | 2019 | 3591 | 0.040 |
Why?
| | Scalp | 1 | 2016 | 6 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2015 | 90 | 0.040 |
Why?
| | Sacrum | 1 | 2015 | 30 | 0.040 |
Why?
| | Heterozygote | 1 | 2015 | 115 | 0.030 |
Why?
| | Cell Nucleus Shape | 1 | 2014 | 2 | 0.030 |
Why?
| | Cell Shape | 1 | 2014 | 9 | 0.030 |
Why?
| | Raphe Nuclei | 1 | 2013 | 8 | 0.030 |
Why?
| | Ventral Tegmental Area | 1 | 2013 | 12 | 0.030 |
Why?
| | Genotype | 1 | 2015 | 423 | 0.030 |
Why?
| | Thoracic Vertebrae | 1 | 2015 | 117 | 0.030 |
Why?
| | Postmortem Changes | 1 | 2012 | 35 | 0.030 |
Why?
| | Amyloid | 1 | 2012 | 52 | 0.030 |
Why?
| | Infant | 1 | 2014 | 642 | 0.030 |
Why?
| | Infant, Newborn | 1 | 2014 | 754 | 0.030 |
Why?
| | Regression Analysis | 1 | 2012 | 319 | 0.030 |
Why?
| | Cervical Vertebrae | 1 | 2013 | 343 | 0.020 |
Why?
| | Complement Membrane Attack Complex | 1 | 2007 | 2 | 0.020 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2007 | 16 | 0.020 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2007 | 9 | 0.020 |
Why?
| | Epithelium | 1 | 2007 | 31 | 0.020 |
Why?
| | Interleukin-1beta | 1 | 2007 | 59 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2007 | 70 | 0.020 |
Why?
| | Necrosis | 1 | 2005 | 29 | 0.020 |
Why?
| | Craniotomy | 1 | 2005 | 29 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 230 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2004 | 29 | 0.020 |
Why?
| | Blotting, Western | 1 | 2004 | 225 | 0.020 |
Why?
| | Gene Library | 1 | 2003 | 10 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 36 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2003 | 77 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2003 | 46 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2004 | 494 | 0.020 |
Why?
| | Electroencephalography | 1 | 2003 | 145 | 0.010 |
Why?
| | Transcription Factors | 1 | 2003 | 180 | 0.010 |
Why?
| | Pregnancy | 1 | 2003 | 457 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2003 | 802 | 0.010 |
Why?
| | Chronic Disease | 1 | 2003 | 544 | 0.010 |
Why?
| | Adolescent | 1 | 2007 | 2667 | 0.010 |
Why?
|
|
Nag's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|